Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
3
×
life sciences
national blog main
boston
san francisco blog main
abbvie
allergan
ally bridge group
alzheimer's disease
big data analytics
black diamond therapeutics
blackrock
bladder cancer
blueprint medicines
cancer
cancer drugs
casdin capital
crispr
cynthia collins
deals
deciphera pharmaceuticals
diabetic nephropathy
editas medicine
eli lilly
endometral cancer
europe blog main
european society for medical oncology
eventide asset management
fda
focal segmental glomerulosclerosis
gene editing
glioblastoma
goldfinch bio
irving investors
jay ghosh
leber congenital amaurosis type 10
loxo oncology
What
biotech
3
×
medicines
3
×
drug
genetic
ipo
lead
new
research
abbvie
alliance
analysis
bio
black
bring
cancer
clinic
companies
company
develop
diamond
diseases
editas
editing
eluded
employing
exits
experimental
gene
goldfinch
hopes
kidney
later
leading
lines
million
molecular
nears
pact
partnership
phase
Language
unset
Current search:
biotech
×
" clinical trials "
×
medicines
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic